コンテンツへスキップ
Merck

Prevention of sevoflurane delirium and agitation with propofol.

Anesthesia progress (2013-06-15)
Zakaria Messieha
要旨

Emergence delirium and agitation (EAD) associated with sevoflurane general anesthesia are very commonly observed in young children. Such events pose a risk for injury as well as decreased parental satisfaction, especially in the ambulatory and office-based setting. This article reviews the different approaches described in the literature to reduce EAD. A novel approach using a Bispectral Index System (BIS)-guided anesthesia with propofol washout technique is proposed as a viable and effective approach to prevent EAD.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
2,6-ジイソプロピルフェノール, 97%
Supelco
Propofol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
2,6-ジイソプロピルフェノール, European Pharmacopoeia (EP) Reference Standard
2,6-ジイソプロピルフェノール, European Pharmacopoeia (EP) Reference Standard